Ovid Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Ovid Therapeutics (Nasdaq: OVID) said management will present at three investor conferences between Feb 25 and Mar 11, 2026, with scheduled times listed for each event.

A live webcast will be available at the company’s Events & Presentations page and an archived replay will be posted for about 30 days.

News Market Reaction – OVID

+7.28%

12 alerts

+7.28% News Effect

+4.1% Peak in 1 hr

+$15M Valuation Impact

$217M Market Cap

0.7x Rel. Volume

On the day this news was published, OVID gained 7.28%, reflecting a notable positive market reaction. Argus tracked a peak move of +4.1% during that session. Our momentum scanner triggered 12 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $15M to the company's valuation, bringing the market cap to $217M at that time.

Data tracked by StockTitan Argus on the day of publication.

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines to treat brain disorders and symptoms caused by excess neural excitability, today announced that the Company’s management will participate in three upcoming investor conferences:

• Oppenheimer 36th Annual Healthcare Life Sciences Conference – Wednesday, February 25th at 11:20 am ET
• 46^th Annual TD Cowen Health Care Conference – Wednesday, March 4^th at 9:50 am ET
• Leerink Partners Global Healthcare Conference 2026 – Wednesday, March 11th at 3:00 pm ET
  
  

A live webcast of the presentations can be accessed through the Events & Presentations section of the company’s website at investors.ovidrx.com. An archived replay of the webcast will be available on the Company’s website following the live presentation for approximately 30 days.

About Ovid Therapeutics

Ovid Therapeutics Inc. is a New York-based biopharmaceutical company dedicated to developing small molecule medicines for brain conditions and symptoms caused by excess neural excitability. Ovid is advancing a pipeline of novel targeted small molecule candidates that modulate the intrinsic and extrinsic factors involved in neuronal hyperexcitability causative of multiple neurological and neuropsychiatric disorders. Ovid is developing: OV329, a next-generation GABA-aminotransferase inhibitor, as a potential therapy for treatment-resistant seizures and other undisclosed indications; and is developing OV4071 and other candidates within a library of compounds that directly activate the KCC2 transporter for multiple CNS disorders. For more information about these and other Ovid research programs, please visit www.ovidrx.com.

Contact

Investor Relations & Media
Victoria Fort
VFort@ovidrx.com
202.361.0445

FAQ

When will Ovid Therapeutics (OVID) present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference?

Ovid will present on Wednesday, February 25, 2026 at 11:20 am ET. According to the company, management will participate and a live webcast will be available on the investor Events & Presentations page.

How can investors watch Ovid Therapeutics (OVID) presentations from the March investor conferences?

Investors can watch a live webcast via the company’s Events & Presentations page at investors.ovidrx.com. According to the company, archived replays will be available on its website for approximately 30 days after each live presentation.

What time is Ovid Therapeutics (OVID) scheduled to present at the 46th Annual TD Cowen Health Care Conference?

Ovid is scheduled to present on Wednesday, March 4, 2026 at 9:50 am ET. According to the company, management will participate and the presentation will be webcast live on the company’s investor site.

When is Ovid Therapeutics (OVID) presenting at the Leerink Partners Global Healthcare Conference 2026?

Ovid will present on Wednesday, March 11, 2026 at 3:00 pm ET. According to the company, the session will be webcast live and an archived replay will be posted on the company website for about 30 days.

Will Ovid Therapeutics (NASDAQ: OVID) provide archived replays of its investor conference presentations?

Yes. The company will post archived replays following each live presentation for approximately 30 days. According to the company, replays will be accessible via the Events & Presentations section on its investor website.